GET TO KNOW THE FARA BOARD
Board of Directors
FARA’s Board is comprised of volunteers dedicated to leading the organization in its mission to treat and cure Friedreich’s ataxia (FA).
FARA Board of Directors
Ron Bartek
Co-founder/President, FARA; Retired U.S. Government Official; Business Consultant
Paul Avery
CEO/President, Elevated Brands, LLC
Maureen Juip
Volunteer, Scientific Communications and Parent Advocate, FARA
Ruth Acton
Director of Finance and Human Resources, FARA
Sanjay Bidichandani, MBBS, PhD
Director Section Head of Genetics, University of Oklahoma College of Medicine, Department of Pediatrics
Brigid T Brennan, Esq
General Counsel and Director of Advocacy, FARA
Alex Fielding
Vice President of Operations, Fielding Manufacturing, Inc
Jennifer Good
President and CEO, Trevi Therapeutics
Thomas Hamilton
Co-Founder, CureFA Foundation; Co-Founder, FA212, LLC
Holly Hedrick, MD
Pediatric Surgeon and Louise Schnaufer Endowed Chair in Pediatric Surgery, The Children's Hospital of Philadelphia
Derek G. Hennecke
Former CEO and President, Xcelience, LLC
Warren Huff
Retired CEO and Chairman, Reata Pharmaceuticals, Inc.
Stephen Klasko, MD
Advisor, General Catalyst. Former President CEO, Jefferson University & Jefferson Health
Katherine Mathews, MD
Vice Chair for Clinical Investigation, Director, Muscular Dystrophy Clinic and Iowa Neuromuscular Program, Professor of Pediatrics – General Neurology The University of Iowa Carver College of Medicine
James McArthur, PhD
President and CEO, PepGen
Tony Plohoros
Principal at 6 Degrees PR
Pat Ritschel
CEO, Atsena Therapeutics, INC
James Rusche
Retired Senior Vice President, Director of Research and Development, Repligen